Oric Pharmaceuticals, Inc.
ORIC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001796280
In the last 90 days, Oric Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 4 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q2 2022
Institutional positions in Oric Pharmaceuticals, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 83
- −15 vs. Q1 2022
- Shares held
- 32.8M
- −1.15M (−3.4%) vs. Q1 2022
- Total value
- $147.1M
- −$34.4M (−18.9%) vs. Q1 2022
- New holders
- 25
- 20 more added
- Sold out
- 40
- 24 more reduced
3 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ORIC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 180 | $1.34B |
| Q1 2026 | 182 | $1.51B |
| Q4 2025 | 165 | $979.6M |
| Q3 2025 | 152 | $1.28B |
| Q2 2025 | 142 | $947.6M |
| Q1 2025 | 143 | $442.0M |
| Q4 2024 | 129 | $611.7M |
| Q3 2024 | 122 | $715.1M |
| Q2 2024 | 113 | $478.3M |
| Q1 2024 | 112 | $879.3M |
| Q4 2023 | 92 | $465.9M |
| Q3 2023 | 90 | $290.7M |
| Q2 2023 | 83 | $353.4M |
| Q1 2023 | 71 | $188.5M |
| Q4 2022 | 64 | $192.1M |
| Q3 2022 | 76 | $104.6M |
| Q2 2022 | 83 | $147.1M |
| Q1 2022 | 101 | $181.7M |
| Q4 2021 | 80 | $512.1M |
| Q3 2021 | 82 | $762.1M |
| Q2 2021 | 78 | $639.4M |
| Q1 2021 | 82 | $874.3M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Oric Pharmaceuticals, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| American International Group, Inc. | 0 | $0 | 0.00% | −15,697−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −14,500−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −14,105−100.0% | Sold out |
| Mirabella Financial Services LLP | 0 | $0 | 0.00% | −13,500−100.0% | Sold out |
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −13,033−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −12,914−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −12,167−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −11,955−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −10,548−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −10,501−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −7,800−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −5,252−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −4,028−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −2,339−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −1,884−100.0% | Sold out |
| Great West Life Assurance Co | 0 | $0 | 0.00% | −1,440−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −1,004−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −506−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −354−100.0% | Sold out |
| FinTrust Capital Advisors, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −264−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −69−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |
| Parametric Portfolio Associates LLC | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |